Hypereosinophilic syndromes and new therapeutic approaches including anti-IL-5.

about

Hypereosinophilic syndromes and new therapeutic approaches including anti-IL-5.

Item

http://www.wikidata.org/entity/Q37755233

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Hypereosinophilic syndromes and new therapeutic approaches including anti-IL-5.

@en

Hypereosinophilic syndromes and new therapeutic approaches including anti-IL-5.

@nl

type

Item

label

Hypereosinophilic syndromes and new therapeutic approaches including anti-IL-5.

@en

Hypereosinophilic syndromes and new therapeutic approaches including anti-IL-5.

@nl

prefLabel

Hypereosinophilic syndromes and new therapeutic approaches including anti-IL-5.

@en

Hypereosinophilic syndromes and new therapeutic approaches including anti-IL-5.

@nl

P1476

Hypereosinophilic syndromes and new therapeutic approaches including anti-IL-5.

@en

P2093

Marc E Rothenberg

http://www.w3.org/2001/XMLSchema#string

Miguel L Stein

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning and expression of the human interleukin 5 receptor

Expression cloning of the human IL-3 receptor cDNA reveals a shared beta subunit for the human IL-3 and GM-CSF receptors

A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome.

Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome.

A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific alpha chain and a beta chain shared with the receptor for GM-CSF

CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy

The EOL-1 cell line as an in vitro model for the study of FIP1L1-PDGFRA-positive chronic eosinophilic leukemia

Overview of monoclonal antibodies in cancer therapy: present and promise

Eosinophilia

Familial eosinophilia maps to the cytokine gene cluster on human chromosomal region 5q31-q33.

P304

633-644

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/1744666X.1.4.633

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2005-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20477604

http://www.w3.org/2001/XMLSchema#string